Part Number : NDC00409-5093-11 | Alternate P/N : NDC00409509311 |
NSN : 6505-01-528-63496505015286349 | Item Name : Ceftazidime For Inj |
Manufacturer : Hospira Inc | CAGE Code : 3VBU6 |
NIIN : 015286349 |
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-528-6349 Item Description: Ceftazidime For Inj | 6505 | 015286349 | M | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
U | A | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
Ndc00409-5093-11 | 2 | 2 | 3 |
MRC | Criteria | Characteristic |
---|---|---|
SUPP | Supplementary Features | ADDVANTAGE VIALS TO BE USED WITH ADDVANTAGE DILUENT |
MRC | Decoded Requirement | Clear Text Reply |
CBBL | Features Provided | STERILE |
CXCY | Part Name Assigned By Controlling Agency | CEFTAZIDIME F/INJ 2GM ADD-VANTAGE VIAL, 10'S |
FEAT | Special Features | STORE IN A DRY STATE, BETWEEN 15 AND 30 DEG. C; PROTECT FROM LIGHT; FOR IV USE; TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; TRAY OF 10S |
AJUC | American Hospital Formulary Service Classification Number | 81206 |
CRLK | Primary Container Content Quantity | 18.000 MILLILITERS AFTER RECONSTITUTION |
AKJA | Active Medicament Medicinal Strength | 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT |
AGXW | Physical Form | POWDER |
CSCW | Total Primary Container Quantity | 10 |
CSGS | Administration | INTRAVENOUS |
CQCT | Primary Container Type | VIAL |
Don't Forget That We Can Give You a Quote for Parts Within 15 Minutes If You Fill Out The Instant RFQ Form.
Request for Quote